| 574 | 0 | 83 |
| 下载次数 | 被引频次 | 阅读次数 |
制备新型蒙药制剂“苏格木勒-3颗粒”,并优选其提取及处方工艺.通过单因素分析方法优化苏格木勒-3挥发油萃取工艺;正交试验优化非挥发油部分提取工艺;采用单因素实验和正交实验优化苏格木勒-3颗粒剂制备工艺,最终确定了挥发油提取工艺条件.大颗粒药材浸泡1 h,提取回流速度为7.5 mL/min,固液比为1∶8 g/mL,提取时间为2 h挥发油提取效果最佳;非挥发油部分提取工艺体积分数为65%的乙醇,固液比为1∶15 g/mL,提取时间为50 min,提取次数为3;筛选出苏格木勒-3颗粒剂处方及制备的最佳工艺,平均得率为95.50%.采用的提取工艺简单,提取效率高,颗粒剂制备工艺可行,为苏格木勒-3的开发提供一定的基础,也对其质量控制提供了科学的实验依据.
Abstract:The novel Mongolian medicine "Sugemule-3 Granules" was prepared, and its extraction and formulation process was optimized. The volatile oil extraction process of Sugemule-3 was optimized by singlefactor analysis; the extraction process of the non-volatile components was optimized by orthogonal test; the preparation process of Sugemule-3 Granules was optimized by single-factor experiments and orthogonal experiments, ultimately determining the volatile oil extraction conditions. The optimal volatile oil extraction was achieved with coarse medicinal granules soaked for 1 h, a reflux rate of 7. 5 mL/min, a solid-liquid ratio of 1∶8 g/mL, and an extraction time of 2 h. The extraction process for non-volatile components used ethanol with a volume fraction of 65%, solid-liquid ratio of 1∶15 g/mL, extraction time of 50 min, and 3 extraction cycles. The optimal formulation and preparation process for Sugemule-3 Granules were screened, with an average yield of 95. 50%. The extraction process is simple and efficient, and the granule preparation process is feasible, providing a foundation for the development of Sugemule-3 and a scientific experimental basis for its quality control.
[1]包建华,娜日苏.蒙药提取苏格木勒-3汤现代研究进展[J].世界最新医学信息文摘,2018,18(8):25-26.
[2]敖道夫,呼日乐巴根,阿拉坦敖日格乐,等.苏格木勒-3汤中白豆蔻-白苣胜挥发油部位体外GC-MS分析[J].中医药导报,2016,22(24):41-46.
[3]韩金美,王树梅,萨础拉.苏格木勒-3汤水提物对小鼠镇静、催眠及失眠模型大鼠催眠的作用机制研究[J].中国药房,2018,29(23):3232-3235.
[4] MISHRA A, PUNIA J K, BLADEN C, et al. Anticonvulsant mechanisms of piperine, a piperidine alkaloid[J]. Channels(Austin),2015,9(5):317-323.
[5]李花花,杨畅,杨艳玲,等.活血止痛凝胶贴膏与微乳凝胶剂的体内外渗透性比较研究[J].中国中药杂志,2022,47(7):1857-1863.
[6]李占军,韩继新.蒙药荜茇中生物碱的药理作用研究进展[J].内蒙古石油化工,2018,44(6):4-6.
[7]吴国华,奥.乌力吉,董圣奎.蒙药苏格木勒-3汤研究进展[J].内蒙古民族大学学报(自然科学版),2009,24(3):337-338.
[8]蒋志,蒋丽霞,李智韬,等.中药汤剂煎煮方法及影响因素研究进展[J].广州中医药大学学报,2022,39(2):458-462.
[9]项丽玲,苗明三.中药散剂的现代研究及思考[J].时珍国医国药,2019,30(11):2720-2723.
[10]王优杰,李益萍,沈岚,等.中药临方颗粒剂的特点与发展设想[J].中国中药杂志,2021,46(15):3746-3752.
[11]李鑫,闫影,孙志伟,等.基于经典名方中药复方颗粒剂的设计研究进展[J].药学研究,2020,39(11):666-669.
[12]姜明月,曹继祥,张兰,等.小儿消积止咳颗粒制粒方式变更研究[J].云南民族大学学报(自然科学版),2025,34(4):436-445.
[13]那溪元,刘毅,殷明阳,等.麻杏止咳平喘颗粒剂成型工艺研究[J].中草药,2016,47(5):767-770.
[14]王丽.中药颗粒剂制备工艺研究进展[J].内蒙古中医药,2018,37(5):103-105.
[15]赵春草,李洁,王瀛峰,等.三七益肾颗粒剂中助悬组合辅料的筛选[J].中国实验方剂学杂志,2015,21(21):5-9.
基本信息:
中图分类号:R29
引用信息:
[1]张弘,刘宏,张晨,等.新型蒙药“苏格木勒-3颗粒”的制备及处方工艺优化[J].云南民族大学学报(自然科学版),2025,34(06):648-655.
基金信息:
内蒙古自治区自然科学基金(2022MS08023); 内蒙古自治区蒙医药协同创新中心科学研究项目(MYYXTYB202108); 内蒙古自治区教育科学“十三五”规划课题(NGJGH2020277); 内蒙古医科大学校级创新训练项目(202210132062)